| 1 |
Bansal A, Ananthasubramaniam K. Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases. Heart Fail Rev 2023;28:387-405. [PMID: 36129644 DOI: 10.1007/s10741-022-10270-6] [Reference Citation Analysis]
|
| 2 |
Totzeck M, Aide N, Bauersachs J, Bucerius J, Georgoulias P, Herrmann K, Hyafil F, Kunikowska J, Lubberink M, Nappi C, Rassaf T, Saraste A, Sciagra R, Slart RHJA, Verberne H, Rischpler C. Nuclear medicine in the assessment and prevention of cancer therapy-related cardiotoxicity: prospects and proposal of use by the European Association of Nuclear Medicine (EANM). Eur J Nucl Med Mol Imaging 2023;50:792-812. [PMID: 36334105 DOI: 10.1007/s00259-022-05991-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 3 |
Campisi R, Merani MF, Rodríguez MI. Assessment of Cardiac Sarcoidosis: FDG PET and BMIPP SPECT. Curr Cardiol Rep 2022;24:1873-82. [PMID: 36282434 DOI: 10.1007/s11886-022-01803-4] [Reference Citation Analysis]
|
| 4 |
Slivnick JA, Wali E, Patel AR. Imaging in Cardiac Sarcoidosis: Complementary Role of Cardiac Magnetic Resonance and Cardiac Positron Emission Tomography. Curr Cardiovasc Imaging Rep 2022. [DOI: 10.1007/s12410-022-09571-z] [Reference Citation Analysis]
|
| 5 |
Cabuk AK, Cabuk G. Real-time three-dimensional echocardiography for detection of cardiac sarcoidosis in the early stage: a cross-sectional single-centre study. Acta Cardiol 2022;77:699-707. [PMID: 35442140 DOI: 10.1080/00015385.2022.2064062] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Kattel S, Enriquez AD. Contemporary approach to catheter ablation of ventricular tachycardia in nonischemic cardiomyopathy. J Interv Card Electrophysiol 2022. [PMID: 36056222 DOI: 10.1007/s10840-022-01363-1] [Reference Citation Analysis]
|
| 7 |
Vidula MK, Bravo PE, Chirinos JA. The Role of Multimodality Imaging in the Evaluation of Heart Failure with Preserved Ejection Fraction. Cardiology Clinics 2022. [DOI: 10.1016/j.ccl.2022.06.002] [Reference Citation Analysis]
|
| 8 |
Kusmirek JE, Mcmillan AB. Cardiac PET/MR. Advances in Clinical Radiology 2022;4:87-109. [DOI: 10.1016/j.yacr.2022.04.008] [Reference Citation Analysis]
|
| 9 |
Schwenck J, Kneilling M, Riksen NP, la Fougère C, Mulder DJ, Slart RJHA, Aarntzen EHJG. A role for artificial intelligence in molecular imaging of infection and inflammation. European J Hybrid Imaging 2022;6:17. [DOI: 10.1186/s41824-022-00138-1] [Reference Citation Analysis]
|
| 10 |
Sperry BW, Bateman TM, Akin EA, Bravo PE, Chen W, Dilsizian V, Hyafil F, Khor YM, Miller RJH, Slart RHJA, Slomka P, Verberne H, Miller EJ, Liu C. Hot spot imaging in cardiovascular diseases: an information statement from SNMMI, ASNC, and EANM. J Nucl Cardiol 2022. [PMID: 35864433 DOI: 10.1007/s12350-022-02985-8] [Reference Citation Analysis]
|
| 11 |
Montera MW, Marcondes-Braga FG, Simões MV, Moura LAZ, Fernandes F, Mangine S, Oliveira Júnior AC, Souza ALAAG, Ianni BM, Rochitte CE, Mesquita CT, de Azevedo Filho CF, Freitas DCA, Melo DTP, Bocchi EA, Horowitz ESK, Mesquita ET, Oliveira GH, Villacorta H, Rossi Neto JM, Barbosa JMB, Figueiredo Neto JA, Luiz LF, Hajjar LA, Beck-da-Silva L, Campos LAA, Danzmann LC, Bittencourt MI, Garcia MI, Avila MS, Clausell NO, Oliveira NA Jr, Silvestre OM, Souza OF, Mourilhe-Rocha R, Kalil Filho R, Al-Kindi SG, Rassi S, Alves SMM, Ferreira SMA, Rizk SI, Mattos TAC, Barzilai V, Martins WA, Schultheiss HP. Brazilian Society of Cardiology Guideline on Myocarditis - 2022. Arq Bras Cardiol 2022;119:143-211. [PMID: 35830116 DOI: 10.36660/abc.20220412] [Reference Citation Analysis]
|
| 12 |
Bohora S, Mumtaz Z, Phadke M, Bhute V, Bhatia V, Vora A, Naik A, Nabar A, Jankharia B, Vaideeswar P, Panicker G, Bhure U, Lokhandwala Y. Long-term, real world experience of ventricular tachycardia and granulomatous cardiomyopathy. Indian Pacing Electrophysiol J 2022:S0972-6292(22)00052-3. [PMID: 35398517 DOI: 10.1016/j.ipej.2022.04.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 13 |
Mathai SV, Patel S, Jorde UP, Rochlani Y. Epidemiology, Pathogenesis, and Diagnosis of Cardiac Sarcoidosis. Methodist DeBakey Cardiovascular Journal 2022;18:78-93. [DOI: 10.14797/mdcvj.1057] [Reference Citation Analysis]
|
| 14 |
Bullock-Palmer RP, Peix A, Aggarwal NR. Nuclear Cardiology in Women and Underrepresented Minority Populations. Curr Cardiol Rep 2022. [PMID: 35262873 DOI: 10.1007/s11886-022-01673-w] [Reference Citation Analysis]
|
| 15 |
Wand AL, Chrispin J, Saad E, Mukherjee M, Hays AG, Gilotra NA. Current State and Future Directions of Multimodality Imaging in Cardiac Sarcoidosis. Front Cardiovasc Med 2021;8:785279. [PMID: 35155601 DOI: 10.3389/fcvm.2021.785279] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 16 |
Brunken RC. Is quantitative fluorine-18 fluorodeoxyglucose PET image analysis the key to Identify cardiac sarcoidosis? J Nucl Cardiol 2022;29:97-100. [DOI: 10.1007/s12350-020-02272-4] [Reference Citation Analysis]
|
| 17 |
Akincioglu C, Malhotra S. Hybrid Cardiac Imaging in Clinical Practice: From Diagnosis to Prognosis and Management. Hybrid Cardiac Imaging for Clinical Decision-Making 2022. [DOI: 10.1007/978-3-030-99391-7_10] [Reference Citation Analysis]
|
| 18 |
Nickander J, Ugander M. Hybrid Cardiac Imaging for the Specialist with Expertise in Cardiac Magnetic Resonance. Hybrid Cardiac Imaging for Clinical Decision-Making 2022. [DOI: 10.1007/978-3-030-99391-7_3] [Reference Citation Analysis]
|
| 19 |
Park J, Young BD, Miller EJ. Potential novel imaging targets of inflammation in cardiac sarcoidosis. J Nucl Cardiol 2021. [PMID: 34734365 DOI: 10.1007/s12350-021-02838-w] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 20 |
Borges-Rosa J, Oliveira-Santos M, Silva R, Gomes A, de Almeida J, Costa G, Gonçalves L, Ferreira MJ. [18F]FDG-PET in cardiac sarcoidosis: A single-centre study in a southern European population. Int J Cardiol 2021:S0167-5273(21)01766-6. [PMID: 34736982 DOI: 10.1016/j.ijcard.2021.10.157] [Reference Citation Analysis]
|
| 21 |
Greulich S, Gatidis S, Gräni C, Blankstein R, Glatthaar A, Mezger K, Müller KAL, Castor T, Mahrholdt H, Häntschel M, Hetzel J, Dittmann H, Nikolaou K, Gawaz M, la Fougère C, Krumm P. Hybrid Cardiac Magnetic Resonance/Fluorodeoxyglucose Positron Emission Tomography to Differentiate Active From Chronic Cardiac Sarcoidosis. JACC Cardiovasc Imaging 2021:S1936-878X(21)00685-9. [PMID: 34656480 DOI: 10.1016/j.jcmg.2021.08.018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
|
| 22 |
Kalra R, Malik S, Chen KA, Ogugua F, Athwal PSS, Elton AC, Velangi PS, Ismail MF, Chhikara S, Markowitz JS, Nijjar PS, von Wald L, Roukoz H, Bhargava M, Perlman D, Shenoy C. Sex Differences in Patients With Suspected Cardiac Sarcoidosis Assessed by Cardiovascular Magnetic Resonance Imaging. Circ Arrhythm Electrophysiol 2021;14:e009966. [PMID: 34546787 DOI: 10.1161/CIRCEP.121.009966] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
|
| 23 |
Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA; 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI) and the European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging 2020;21:1320-30. [PMID: 33245759 DOI: 10.1093/ehjci/jeaa299] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 5.5] [Reference Citation Analysis]
|
| 24 |
Barrios L, Dilling-boer D, Jacobs A, Ghekiere O, Timmermans P. Hidden under the Surface: A Rare Cause of Repeated Syncope in a Patient with Recent Pacemaker Implantation. Hearts 2021;2:288-93. [DOI: 10.3390/hearts2020023] [Reference Citation Analysis]
|
| 25 |
Moon JB, Cho SG, Yoo SW, Bom HH. Increasing Use of Cardiac PET/CT for Inflammatory and Infiltrative Heart Diseases in Korea. Chonnam Med J 2021;57:139-43. [PMID: 34123742 DOI: 10.4068/cmj.2021.57.2.139] [Reference Citation Analysis]
|
| 26 |
Chaudhari AJ, Badawi RD. Application-specific nuclear medicalin vivoimaging devices. Phys Med Biol 2021;66. [PMID: 33770765 DOI: 10.1088/1361-6560/abf275] [Reference Citation Analysis]
|
| 27 |
Tana C, Mantini C, Donatiello I, Mucci L, Tana M, Ricci F, Cipollone F, Giamberardino MA. Clinical Features and Diagnosis of Cardiac Sarcoidosis. J Clin Med 2021;10:1941. [PMID: 34062709 DOI: 10.3390/jcm10091941] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 28 |
Pelzer T, Jung P. [Pulmonary and Cardiac Sarcoidosis - Diagnosis and Therapy]. Dtsch Med Wochenschr 2021;146:335-43. [PMID: 33648003 DOI: 10.1055/a-1239-4492] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
|
| 29 |
Rosenfeld LE, Chung MK, Harding CV, Spagnolo P, Grunewald J, Appelbaum J, Sauer WH, Culver DA, Joglar JA, Lin BA, Jellis CL, Dickfeld TM, Kwon DH, Miller EJ, Cremer PC, Bogun F, Kron J, Bock A, Mehta D, Leis P, Siontis KC, Kaufman ES, Crawford T, Zimetbaum P, Zishiri ET, Singh JP, Ellenbogen KA, Chrispin J, Quadri S, Vincent LL, Patton KK, Kalbfleish S, Callahan TD, Murgatroyd F, Judson MA, Birnie D, Okada DR, Maulion C, Bhat P, Bellumkonda L, Blankstein R, Cheng RK, Farr MA, Estep JD. Arrhythmias in Cardiac Sarcoidosis Bench to Bedside: A Case-Based Review. Circ Arrhythm Electrophysiol 2021;14:e009203. [PMID: 33591816 DOI: 10.1161/CIRCEP.120.009203] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 30 |
Rischpler C, Schlosser T, Umutlu L, Rassaf T, Krause BJ. [What actually happens … in hybrid imaging?]. Radiologe 2020;60:1153-61. [PMID: 33215289 DOI: 10.1007/s00117-020-00779-y] [Reference Citation Analysis]
|
| 31 |
Peix A. Nuclear Imaging in Acute Coronary Syndromes. Nuclear Cardiology 2021. [DOI: 10.1007/978-3-030-62195-7_11] [Reference Citation Analysis]
|
| 32 |
Casali M, Lauri C, Altini C, Bertagna F, Cassarino G, Cistaro A, Erba AP, Ferrari C, Mainolfi CG, Palucci A, Prandini N, Baldari S, Bartoli F, Bartolomei M, D'Antonio A, Dondi F, Gandolfo P, Giordano A, Laudicella R, Massollo M, Nieri A, Piccardo A, Vendramin L, Muratore F, Lavelli V, Albano D, Burroni L, Cuocolo A, Evangelista L, Lazzeri E, Quartuccio N, Rossi B, Rubini G, Sollini M, Versari A, Signore A. State of the art of (18)F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation. Clin Transl Imaging 2021;9:299-339. [PMID: 34277510 DOI: 10.1007/s40336-021-00445-w] [Cited by in Crossref: 30] [Cited by in F6Publishing: 28] [Article Influence: 15.0] [Reference Citation Analysis]
|
| 33 |
Dorbala S, Falk RH. Imaging Cardiac Sarcoidosis, Amyloidosis, and Cardiovascular Prosthetic Infections. Atlas of Nuclear Cardiology 2021. [DOI: 10.1007/978-3-030-49885-6_13] [Reference Citation Analysis]
|
| 34 |
Haaf P, Giorgetti A, Caobelli F, Zellweger MJ. Cardiac Sarcoidosis. Imaging of Inflammation and Infection in Cardiovascular Diseases 2021. [DOI: 10.1007/978-3-030-81131-0_2] [Reference Citation Analysis]
|
| 35 |
Nappi C, Ponsiglione A, Imbriaco M, Cuocolo A. 18F-FDG PET/CMR in cardiac sarcoidosis: A wild card in the deck? J Nucl Cardiol 2020. [PMID: 33145740 DOI: 10.1007/s12350-020-02427-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 36 |
Slart RHJA, Glaudemans AWJM, Gheysens O, Lubberink M, Kero T, Dweck MR, Habib G, Gaemperli O, Saraste A, Gimelli A, Georgoulias P, Verberne HJ, Bucerius J, Rischpler C, Hyafil F, Erba PA; 4Is Cardiovascular Imaging: a joint initiative of the European Association of Cardiovascular Imaging (EACVI)., European Association of Nuclear Medicine (EANM). Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM. Eur J Nucl Med Mol Imaging 2021;48:1016-39. [PMID: 33106926 DOI: 10.1007/s00259-020-05066-5] [Cited by in Crossref: 26] [Cited by in F6Publishing: 30] [Article Influence: 8.7] [Reference Citation Analysis]
|
| 37 |
Sankjmiron SS, Kyprianou K, Cherk MH, Nadebaum DP, Beech PA, Khor R, Zimmet H, Hare JL, Larby A, Yap KS, Barber TW. Excellent suppression of physiological myocardial FDG activity in patients with cardiac sarcoidosis. J Med Imaging Radiat Oncol 2021;65:54-9. [PMID: 33103345 DOI: 10.1111/1754-9485.13121] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
|
| 38 |
Slomka PJ, Moody JB, Miller RJH, Renaud JM, Ficaro EP, Garcia EV. Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications. J Nucl Med 2021;62:168-76. [PMID: 33067339 DOI: 10.2967/jnumed.120.242537] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 39 |
Slomka PJ, Moody JB, Miller RJH, Renaud JM, Ficaro EP, Garcia EV. Quantitative clinical nuclear cardiology, part 2: Evolving/emerging applications. J Nucl Cardiol 2021;28:115-27. [PMID: 33067750 DOI: 10.1007/s12350-020-02337-4] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 40 |
Schindler TH, Bateman TM, Berman DS, Chareonthaitawee P, De Blanche LE, Dilsizian V, Dorbala S, Gropler RJ, Shaw L, Soman P, Winchester DE, Verberne H, Ahuja S, Beanlands RS, Di Carli MF, Murthy VL, Ruddy TD, Schwartz RG. Appropriate Use Criteria for PET Myocardial Perfusion Imaging. J Nucl Med 2020;61:1221-65. [PMID: 32747510 DOI: 10.2967/jnumed.120.246280] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 6.3] [Reference Citation Analysis]
|
| 41 |
Louis DW, Papaila A, Sheikh W, Atalay MK, Abbott BG. Multimodal Imaging for the Diagnosis of Isolated Cardiac Sarcoidosis. JACC: Case Reports 2020;2:1074-1078. [DOI: 10.1016/j.jaccas.2020.05.021] [Reference Citation Analysis]
|
| 42 |
Te HS, Perlman DM, Shenoy C, Steinberger DJ, Cogswell RJ, Roukoz H, Peterson EJ, Zhang L, Allen TL, Bhargava M. Clinical characteristics and organ system involvement in sarcoidosis: comparison of the University of Minnesota Cohort with other cohorts. BMC Pulm Med 2020;20:155. [PMID: 32487134 DOI: 10.1186/s12890-020-01191-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 4.7] [Reference Citation Analysis]
|
| 43 |
Chazal T, Varnous S, Guihaire J, Goeminne C, Launay D, Boignard A, Vermes E, Dorent R, Camilleri L, Lelong B, Epailly E, Lebreton G, Waintraub X, Cluzel P, Maksud P, Fouret P, Leprince P, Grenier P, Amoura Z, Cohen Aubart F. Sarcoidosis diagnosed on granulomas in the explanted heart after transplantation: Results of a French nationwide study. International Journal of Cardiology 2020;307:94-100. [DOI: 10.1016/j.ijcard.2019.12.066] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
|
| 44 |
Smedema JP, Ainslie G, Crijns HJGM. Review: Contrast-enhanced magnetic resonance in the diagnosis and management of cardiac sarcoidosis. Prog Cardiovasc Dis 2020;63:271-307. [PMID: 32330463 DOI: 10.1016/j.pcad.2020.03.011] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 45 |
Elwazir MY, Bois JP, Abouezzeddine OF, Chareonthaitawee P. Imaging cardiac sarcoidosis and infiltrative diseases: diagnosis and therapeutic response. Q J Nucl Med Mol Imaging 2020;64. [DOI: 10.23736/s1824-4785.20.03235-5] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
|
| 46 |
Keijsers RGM, Grutters JC. In Which Patients with Sarcoidosis Is FDG PET/CT Indicated? J Clin Med 2020;9:E890. [PMID: 32213991 DOI: 10.3390/jcm9030890] [Cited by in Crossref: 25] [Cited by in F6Publishing: 29] [Article Influence: 8.3] [Reference Citation Analysis]
|
| 47 |
Treglia G, Muoio B. Evidence-Based PET for Infectious and Inflammatory Diseases. Evidence-based Positron Emission Tomography 2020. [DOI: 10.1007/978-3-030-47701-1_12] [Reference Citation Analysis]
|
| 48 |
Skowasch D, Gaertner F, Marx N, Meder B, Müller-quernheim J, Pfeifer M, Schrickel JW, Yilmaz A, Grohé C. Diagnostik und Therapie der kardialen Sarkoidose: Konsensuspapier der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin (DGP) und Deutschen Gesellschaft für Kardiologie – Herz und Kreislaufforschung (DGK). Kardiologe 2020;14:14-25. [DOI: 10.1007/s12181-019-00359-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 49 |
Van Schandevyl S, Waterschoot R, De Vos N, Devos D, Goethals I. Cardiac sarcoidosis: the complementary role of 18F-FDG PET and MRI. J Cardiovasc Med (Hagerstown) 2020;21:335-6. [PMID: 31809284 DOI: 10.2459/JCM.0000000000000919] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
| 50 |
Treglia G. Diagnostic Performance of 18F-FDG PET/CT in Infectious and Inflammatory Diseases according to Published Meta-Analyses. Contrast Media Mol Imaging. 2019;2019:3018349. [PMID: 31427907 DOI: 10.1155/2019/3018349] [Cited by in Crossref: 45] [Cited by in F6Publishing: 51] [Article Influence: 11.3] [Reference Citation Analysis]
|
| 51 |
Ahluwalia M, Pan S, Ghesani M, Phillips LM. A new era of imaging for diagnosis and management of cardiac sarcoidosis: Hybrid cardiac magnetic resonance imaging and positron emission tomography. J Nucl Cardiol 2019;26:1996-2004. [DOI: 10.1007/s12350-019-01770-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 52 |
Boutagy NE, Feher A, Alkhalil I, Umoh N, Sinusas AJ. Molecular Imaging of the Heart. Compr Physiol 2019;9:477-533. [PMID: 30873600 DOI: 10.1002/cphy.c180007] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
|
| 53 |
Sigman SR. Diagnosis and Therapy of Cardiac Sarcoidosis: A Clinical Perspective. US Cardiology Review 2019;13:41-5. [DOI: 10.15420/usc.2018.3.1] [Reference Citation Analysis]
|
| 54 |
Rischpler C, Nekolla SG, Heusch G, Umutlu L, Rassaf T, Heusch P, Herrmann K, Nensa F. Cardiac PET/MRI-an update. Eur J Hybrid Imaging 2019;3:2. [PMID: 34191143 DOI: 10.1186/s41824-018-0050-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
|
| 55 |
Varghese M, Shahab Z, Miller EJ. Cardiac Sarcoidosis. Sarcoidosis 2019. [DOI: 10.1016/b978-0-323-54429-0.00009-4] [Reference Citation Analysis]
|
| 56 |
Sperry BW, Hachamovitch R. The Authors Reply:. JACC: Cardiovascular Imaging 2019;12:219. [DOI: 10.1016/j.jcmg.2018.11.007] [Reference Citation Analysis]
|
| 57 |
Flores RJ, Flaherty KR, Jin Z, Bokhari S. The prognostic value of quantitating and localizing F-18 FDG uptake in cardiac sarcoidosis. J Nucl Cardiol 2020;27:2003-10. [PMID: 30421379 DOI: 10.1007/s12350-018-01504-y] [Cited by in Crossref: 22] [Cited by in F6Publishing: 26] [Article Influence: 4.4] [Reference Citation Analysis]
|
| 58 |
van der Bijl P, Podlesnikar T, Bax JJ, Delgado V. Predicción del riesgo de muerte súbita cardiaca: el papel de la resonancia magnética cardiaca. Revista Española de Cardiología 2018;71:961-70. [DOI: 10.1016/j.recesp.2018.04.040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
|
| 59 |
Lindner O, Bauersachs J, Bengel F, Burchert W, vom Dahl J, Dörr R, Hacker M, Kelm M, Rassaf T, Rischpler C, Schäfer W, Schäfers M, Silber S, Zimmermann R. Positionspapier Nuklearkardiologie – Update 2018. Kardiologe 2018;12:303-311. [DOI: 10.1007/s12181-018-0266-1] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
|
| 60 |
Yatsynovich Y, Valencia D, Petrov M, Linares JD, Rahman MM, Dittoe N. Updates on the Role of Imaging in Cardiac Sarcoidosis. Curr Treat Options Cardio Med 2018;20. [DOI: 10.1007/s11936-018-0670-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 61 |
Signore A, Lazzeri E, Glaudemans AWJM. Infection and inflammation imaging standardization: the EANM guidelines. Clin Transl Imaging 2018;6:253-5. [DOI: 10.1007/s40336-018-0288-5] [Reference Citation Analysis]
|
| 62 |
van der Bijl P, Podlesnikar T, Bax JJ, Delgado V. Sudden Cardiac Death Risk Prediction: The Role of Cardiac Magnetic Resonance Imaging. Rev Esp Cardiol (Engl Ed) 2018;71:961-70. [PMID: 29970349 DOI: 10.1016/j.rec.2018.05.019] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
|
| 63 |
Broski SM, Goenka AH, Kemp BJ, Johnson GB. Clinical PET/MRI: 2018 Update. AJR Am J Roentgenol 2018;211:295-313. [PMID: 29949413 DOI: 10.2214/AJR.18.20001] [Cited by in Crossref: 45] [Cited by in F6Publishing: 46] [Article Influence: 9.0] [Reference Citation Analysis]
|
| 64 |
Phillips LM. Case Presentation Commentary on “A case of longitudinal care of a patient with cardiac sarcoidosis”. J Nucl Cardiol 2018;25:457-457. [DOI: 10.1007/s12350-018-1215-x] [Reference Citation Analysis]
|
| 65 |
Tedrow U. Assembling the Pieces of the Puzzle. JACC: Clinical Electrophysiology 2018;4:304-306. [DOI: 10.1016/j.jacep.2018.01.018] [Reference Citation Analysis]
|
